- Citations, last 5 years
- 2 490
- Works, last 5 years
- 440
- h-index
- 112
- Scientists listed
- 28
- Grants since 2016
- 3 213
Grants received
2017–2022 · research · R01
Macrophage development and specification in mice.
Frederic Geissmann · Kettering University · funded by National Institutes of Health
2017–2021 · fellowship · F31
Investigating Bruton's Tyrosine Kinase Dependency in Primary Central Nervous System Lymphoma
Sarah Tang · Kettering University · funded by National Institutes of Health
2017–2024 · research · R35
Isolation, characterization and translational development of glioma stem cells
Luis Fernando Parada · Kettering University · funded by National Institutes of Health
2017–2022 · research · R01
P-selectin-Mediated Targeting of PI3K Nanomedicines to the Tumor Microenvironment
Daniel Alan Heller · Kettering University · funded by National Institutes of Health
2017–2021 · research · R01
Molecular and genetic analysis of novel Slicer-dependent miRNA pathways in blood
Michael Kharas · Kettering University · funded by National Institutes of Health
2017–2022 · research · R01
BRMS1-mediated suppression of metastases in p53 mutant lung adenocarcinoma
David R Jones · Kettering University · funded by National Institutes of Health
2017–2020 · research · R01
Inferential methods to assess the incremental value of new biomarkers in risk classification models
Glenn Heller · Kettering University · funded by National Institutes of Health
2017–2022 · research · R01
Alternative pre-mRNA splicing of mu opioid receptor gene and mu opioid actions
Ying-Xian Pan · Kettering University · funded by National Institutes of Health
2017–2022 · research · R25
Tobacco Treatment Training for Cancer Care Providers
Jamie S. Ostroff · Kettering University · funded by National Institutes of Health
2017–2022 · research · R01
Exploiting ferroportin for cancer imaging and therapy
Jan Grimm · Kettering University · funded by National Institutes of Health
2017–2022 · research · R01
Macrophage development and specification in mice.
Frederic Geissmann · Kettering University · funded by National Institutes of Health
2017–2022 · research · R01
Exploring PSMA Biology in Tumor neovasculature
Jan Grimm · Kettering University · funded by National Institutes of Health
2017–2018 · career development · K99
Overcome the lineage plasticity conferred targeted therapy resistance in advanced prostate cancer
Ping Mu · Kettering University · funded by National Institutes of Health
2017–2022 · research · R01
Exploring PSMA Biology in Tumor neovasculature
Jan Grimm · Kettering University · funded by National Institutes of Health
2017–2022 · research · R01
Macrophage development and specification in mice.
Frederic Geissmann · Kettering University · funded by National Institutes of Health
2017–2019 · research · R01
Immuno-PET imaging of high-grade neuroendocrine lung tumors using 89Zr-rovalpituzumab, a DLL3-targeting monoclonal antibody
Jason S. Lewis · Kettering University · funded by National Institutes of Health
2017–2022 · research · R01
Regulation of Nfil3 in innate lymphocyte-mediated host immunity
Joseph Chai-Yuen Sun · Kettering University · funded by National Institutes of Health
2017–2020 · research · R00
The origins of chromosome rearrangement in the cancer genome
John Maciejowski · Kettering University · funded by National Institutes of Health
2017–2022 · research · R35
Investigating long noncoding RNAs as regulators of the p53 pathway functions.
Adam Schmitt · Kettering University · funded by National Institutes of Health
2017–2019 · fellowship · F99
Role of the tumor microenvironment in promoting drug resistance in castration resistant prostate cancer
Zeda Zhang · Kettering University · funded by National Institutes of Health
2017–2022 · research · R01
Exploiting ferroportin for cancer imaging and therapy
Jan Grimm · Kettering University · funded by National Institutes of Health
2017–2022 · research · R25
Quantitative Sciences Summer Undergraduate Research Experience (QSURE) Fellowship
Elena B Elkin · Kettering University · funded by National Institutes of Health
2017–2020 · cooperative agreement · U01
Defining neoantigen immunodominance for antigen selection and biomarker discovery in human pancreatic cancer immunotherapy
Vinod P Balachandran · Kettering University · funded by National Institutes of Health
2017–2021 · research · R01
Lineages and pathophysiology of clonal histiocytic disorders
Frederic Geissmann · Kettering University · funded by National Institutes of Health
2017–2022 · research · R01
Programming age in iPS models of Alzheimer's disease
Lorenz P. Studer · Kettering University · funded by National Institutes of Health
2017–2021 · research · R01
Molecular and genetic analysis of novel Slicer-dependent miRNA pathways in blood
Michael Kharas · Kettering University · funded by National Institutes of Health
2017–2021 · research · R01
Lineages and pathophysiology of clonal histiocytic disorders
Frederic Geissmann · Kettering University · funded by National Institutes of Health
2017–2025 · research · R35
Isolation, characterization and translational development of glioma stem cells
Luis Fernando Parada · Kettering University · funded by National Institutes of Health
2017–2021 · research · R21
Identification of Essential Areas of the Brain in Pre-Operative Brain Tumor Patients Using BOLD fMRI and Independent Physiological Parameters
Andrei I Holodny · Kettering University · funded by National Institutes of Health
2017–2020 · research · R00
The origins of chromosome rearrangement in the cancer genome
John Maciejowski · Kettering University · funded by National Institutes of Health
2017–2028 · research · R25
Tobacco Treatment Training for Cancer Care Providers
Jamie S. Ostroff · Kettering University · funded by National Institutes of Health
2017–2022 · research · R01
Protein and proteolytic activity biomarkers of early stage pancreatic cancer
Paul Tempst · Kettering University · funded by National Institutes of Health
2017–2020 · research · R21
Identification of Essential Areas of the Brain in Pre-Operative Brain Tumor Patients Using BOLD fMRI and Independent Physiological Parameters
Andrei I Holodny · Kettering University · funded by National Institutes of Health
2017–2019 · research · R21
Imaging the efficacy of TRAIL-enhanced cancer immunotherapy
Prasad S. Adusumilli · Kettering University · funded by National Institutes of Health
2017–2022 · research · R01
The role of reorganization energy in achieving selective kinase inhibition
John Damon Chodera · Kettering University · funded by National Institutes of Health
2017–2022 · research · R01
Schwann Cell Reprogramming and Cancer Perineural Invasion
Richard J Wong · Kettering University · funded by National Institutes of Health
2017–2022 · research · R01
BRMS1-mediated suppression of metastases in p53 mutant lung adenocarcinoma
David R Jones · Kettering University · funded by National Institutes of Health
2017–2025 · research · R01
Mechanisms of Lipid Droplet Formation
Robert V Farese · Kettering University · funded by National Institutes of Health
2017–2020 · research · R21
uCoil NMR platform for robust and high-throughput analysis of in vitro metabolic flux on living cells
Kayvan R Keshari · Kettering University · funded by National Institutes of Health
2017–2020 · research · R01
Inferential methods to assess the incremental value of new biomarkers in risk classification models
Glenn Heller · Kettering University · funded by National Institutes of Health
